BriaCell Therapeutics

/BriaCell Therapeutics

Follow-on/Uplisting: BriaCell is an immuno-oncology focused biotechnology company developing targeted and safe approaches for the management of cancer, with a focus on advanced breast cancer.

Symbol

Last Closing Price
$5.34

Shares
5,882,353

Anticipated Date
February 24, 2021

Underwriters

This offering is no longer available

To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange